Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS, page-154

mateyi agree completely

there are some long-time posters here that areall over the stock, much better than some of the Analysts are .... andwell done to them.

ialso see those Billions around the corner, for mere Imaging - the cash cow andnot to mention the Unexpected which seems to be fairly frequent,
i am also a believer in success breeds success -and TLX has that in spades.

as for the Nasdaq Currency - yeh would have been nice but im sure TLX canentice talented staff in ASX shares or just salary alone if they really wantthem ... and regarding the placement funds. i guess every company wants or hasa need for an extra $300m

but i don't need it all today, im quite enjoyingthe building process.

i really think that Nasdaq listing, or lackthereof will be a blessing in the end. it has not been wasted.

i concur, TLX and the Radiopharma industry isjust beginning.

ican't tell you how many times i bought CSL at $30-$50, before the 3:1 split andthought they were expensive (and i was in the industry) at that time.now equivalent = $900

for the life of me, i cannot understand whyMerck or Bristol or Novartis don't lob a bid in for TLX. i fullyunderstand they will not get control, but they might get a 10% stake which forthem is an insurance policy. in case TLX continues delivering

the other day, when they went in Trading Halt,that was my first thought.